scispace - formally typeset
O

Olympia Zarkotou

Researcher at National and Kapodistrian University of Athens

Publications -  29
Citations -  1104

Olympia Zarkotou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Colistin & Klebsiella pneumoniae. The author has an hindex of 13, co-authored 24 publications receiving 939 citations.

Papers
More filters
Journal ArticleDOI

Linezolid dependence in Staphylococcus epidermidis bloodstream isolates.

TL;DR: Linezolid dependence could account for increasing LRSE emergence and is documented among 5 highly linezolid-resistant (LRSE) Staphylococcus epidermidis bloodstream isolates that grew substantially faster at 32 µg/mL lineZolid presence.
Journal ArticleDOI

Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria

TL;DR: By implementation of the new 2010 CLSI breakpoints, a considerable proportion of ESBL-possessing Enterobacteriaceae would be reported as susceptible, mostly to ceftazidime and cefepime, leading to possible infection control and therapeutic implications.
Journal ArticleDOI

Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.

TL;DR: The implementation of IC interventions reduced the BSI incidence rates, particularly for ICU patients, however, factors possibly related to the restrictions of human and material resources apparently contributed to the observed expansion of BSI in the authors' endemic setting.
Journal ArticleDOI

Whole-genome typing and characterization of blaVIM19-harbouring ST383 Klebsiella pneumoniae by PFGE, whole-genome mapping and WGS

TL;DR: This study demonstrates the application of WGM to understanding the epidemiology of hospital-associated K. pneumoniae and presents the first longitudinal genomic characterization of the highly dynamic carbapenem-resistant ST383 K.neumoniae clone that is rapidly gaining importance in Europe.